Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock - $0.01 Par Value
-
Shares outstanding
-
46.4M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
41.2M
-
Shares change
-
-71K
-
Total reported value, excl. options
-
$897M
-
Value change
-
-$2.88M
-
Number of buys
-
91
-
Number of sells
-
-97
-
Price
-
$21.78
Significant Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) as of Q3 2022
240 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value as of Q3 2022.
AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.2M shares
of 46.4M outstanding shares and own 88.77% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.38M shares), VANGUARD GROUP INC (5.39M shares), DIMENSIONAL FUND ADVISORS LP (2.83M shares), RGM Capital, LLC (2.78M shares), Paradice Investment Management LLC (2.34M shares), STATE STREET CORP (2.01M shares), GOLDMAN SACHS GROUP INC (1.57M shares), WESTWOOD HOLDINGS GROUP INC (1.21M shares), Neuberger Berman Group LLC (871K shares), and GEODE CAPITAL MANAGEMENT, LLC (827K shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.